stars 1 stars 2 stars 3

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast. We employ over 1,300+ staff and operate from state-of-the-art manufacturing and clinical facilities in the US and UK. Our people make Quotient Sciences a special place to work. We are a dedicated team passionate about innovating and transforming drug development to help our customers develop new medicines for patients in need. We recruit people that are committed to making a difference, who excel at customer service and are always willing to go the extra mile. Teamwork is integral to our culture and success — helping, supporting and mentoring run through our DNA. Expect to join an empowering and innovative culture, where we encourage continuous improvement and offer opportunities to learn and develop every day.

Website https://www.quotientsciences.com
Revenue $394.4 million
Employees 1,011 (645 on RocketReach)
Founded 1990
Phone +44 800 769 3518
Technologies
Industry Pharmaceutical Manufacturing, Pharmaceuticals, Clinical Trials, CDMO, Healthcare, Health Care, Formulation Development, Manufacturing, Phase I & II Clinical Trial Manufacturing, Medical, Translational Pharmaceutics, Pharmaceutical, High Potency Handling, Real-time Adaptive Manufacturing, Commercial Manufacturing, Solubility Enhancement, Modified Release, Pediatric Formulation Development, CRO, First-in-Human, Clinical Pharmacology, Relative Bioavailability, Pharmacokinetics, Drug-Drug Interaction, Human ADME / 14C, Data Sciences, Modelling & Simulation
Keywords Drug Development, Contract Development And Manufacturing, Cdmo Services, Pharmaceutical Development, Drug Manufacturing, Clinical Trials, Biopharmaceutical Manufacturing, Drug Product Development, Pharmaceutical Services, Pharmaceutical Research, Medicines Development, Formulation Development, Process Development, Biologics Manufacturing, Analytical Testing, Drug Delivery, Regulatory Affairs, Quality Assurance, Lifecycle Management
Competitors ICON plc, Research Pharmaceutical Services, Labcorp, PPD, Syneos Health, Charles River Laboratories, Medpace, WuXi AppTec, Covance, Chiltern International B.V. +34 more (view full list)
SIC SIC Code 283 Companies, SIC Code 28 Companies
NAICS NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies

Quotient Sciences Questions

The Quotient Sciences annual revenue was $394.4 million in 2026.

Thierry van Nieuwenhove is the CEO of Quotient Sciences.

645 people are employed at Quotient Sciences.

The NAICS codes for Quotient Sciences are [3254, 325, 32541, 32].

The SIC codes for Quotient Sciences are [283, 28].

Top Quotient Sciences Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users